Skip to main content

Advertisement

Log in

Treatment of hepatitis B virus-related polyarteritis nodosa: two case reports and a review of the literature

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

A substantial number of cases of polyarteritis nodosa (PAN) are related to hepatitis B virus (HBV) infection. Different treatment strategies are reported in the literature. The aim of this study was to review 15 years of literature (1988–2002) to determine the optimal treatment for HBV-related PAN at present, and to discuss the indications and mechanism of action of corticosteroids in HBV-related PAN, as many physicians are reluctant to use these in the presence of HBV infection. The first patient stopped his initial treatment, relapsed and died of cerebral infarction. The second case illustrates the favorable outcome with the standard treatment: corticosteroids, lamivudine and plasma exchanges. If adequate follow-up is possible, antiviral agents as well as corticosteroids are indicated in HBV-related PAN. Corticosteroids diminish inflammation and corticosteroid withdrawal induces an alanine aminotransferase (ALT) rebound in patients with a low baseline ALT level. Antiviral agents are essential, as they reduce the production of HBV antigens and help to achieve hepatitis B early antigen (HBeAg) seroconversion. Plasma exchanges reduce the level of circulating immune complexes and are included in the treatment protocol of all recent studies. However, their effect has not been evaluated in controlled trials. We concluded that if adequate follow-up is possible, antiviral agents as well as corticosteroids are indicated in HBV-related PAN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ALT:

Alanine aminotransferase

HBV:

Hepatitis B virus

PAN:

Polyarteritis nodosa

References

  1. Trepo C, Guillevin L (2001) Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun 16:269–274

    Article  CAS  PubMed  Google Scholar 

  2. Guillevin L, Lhote F, Jarrousse B et al. (1992) Polyarteritis nodosa related to hepatitis B virus. A retrospective study of 66 patients. Ann Med Interne (Paris) 143 Suppl 1:63–74

    Google Scholar 

  3. McMahon BJ, Heyward WL, Templin DW, Clement D, Lanier AP (1989) Hepatitis B-associated polyarteritis nodosa in Alaskan Eskimos: clinical and epidemiologic features and long-term follow-up. Hepatology 9:97–101

    CAS  PubMed  Google Scholar 

  4. Guillevin L, Mahr A, Cohen P et al. (2003) Short-term corticosteroids then lamivudine and plasma exchanges to treat hepatitis B virus-related polyarteritis nodosa. Arthritis Rheum 2003 (in press)

  5. Guillevin L, Lhote F, Cohen P et al. (1995) Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine (Baltimore) 74:238–253

  6. Guillevin L, Lhote F, Leon A, Fauvelle F, Vivitski L, Trepo C (1993) Treatment of polyarteritis nodosa related to hepatitis B virus with short term steroid therapy associated with antiviral agents and plasma exchanges. A prospective trial in 33 patients. J Rheumatol 20:289–298

    CAS  PubMed  Google Scholar 

  7. Guillevin L, Lhote F, Sauvaget F et al. (1994) Treatment of polyarteritis nodosa related to hepatitis B virus with interferon-alpha and plasma exchanges. Ann Rheum Dis 53:334–337

    CAS  PubMed  Google Scholar 

  8. Avsar E, Savas B, Tozun N, Ulusoy NB, Kalayci C (1998) Successful treatment of polyarteritis nodosa related to hepatitis B virus with interferon alpha as first-line therapy. J Hepatol 28:525–526

    Article  CAS  PubMed  Google Scholar 

  9. Simsek H, Telatar H (1995) Successful treatment of hepatitis B virus-associated polyarteritis nodosa by interferon alpha alone. J Clin Gastroenterol 20:263–265

    CAS  PubMed  Google Scholar 

  10. Mouthon L, Deblois P, Sauvaget F, Meyrier A, Callard P, Guillevin L (1995) Hepatitis B virus-related polyarteritis nodosa and membranous nephropathy. Am J Nephrol 15:266–269

    CAS  PubMed  Google Scholar 

  11. Lam KC, Lai CL, Trepo C, Wu PC (1981) Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med 304:380–386

    CAS  PubMed  Google Scholar 

  12. Wood JR, Czaja AJ, Taswell HF, Ludwig J, Rakela J, Chase R (1987) Hepatitis B virus deoxyribonucleic acid in serum during hepatitis B e antigen clearance in corticosteroid-treated severe chronic active hepatitis B. Gastroenterology 93:1225–1230

    CAS  PubMed  Google Scholar 

  13. Chiaramonte M, Floreani A, Martines D, De Lazzari F, Naccarato R (1982) Hepatitis B virus infection and cyclophosphamide. Ann Intern Med 97:451–452

    CAS  Google Scholar 

  14. Trepo C, Ouzan D, Delmont J, Tremisi J (1988) Superiority of a new etiopathogenic treatment curing periarteritis nodosa caused by hepatitis B virus, using a combination of brief corticotherapy, vidarabine and plasma exchange (in French). Presse Med 17:1527–1531

    CAS  PubMed  Google Scholar 

  15. Schalm S, De Man R, Janssen H (2002) Combination and newer therapies for chronic hepatitis B. J Gastroenterol Hepatol 17 Suppl 3:S338–S341

    Article  Google Scholar 

  16. Perrillo RP (2000) Short-term corticosteroid therapy in combination with lamivudine: A case of deja vu? Hepatology 32:663–665.

    CAS  PubMed  Google Scholar 

  17. Liaw YF, Tsai SL, Chien RN, Yeh CT, Chu CM (2000) Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B. Hepatology 32:604–609

    CAS  PubMed  Google Scholar 

  18. Zarski JP, Causse X, Cohard M, Cougnard J, Trepo C (1994) A randomized, controlled trial of interferon alfa-2b alone and with simultaneous prednisone for the treatment of chronic hepatitis B. French Multicenter Group. J Hepatol 20:735–741

    CAS  PubMed  Google Scholar 

  19. Dienstag JL, Schiff ER, Wright TL et al. (1999) Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med 341:1256–1263

    CAS  PubMed  Google Scholar 

  20. Leung NW, Lai CL, Chang TT et al. (2001) Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology 33:1527–1532

    Article  CAS  PubMed  Google Scholar 

  21. Guillevin L, Lhote F, Cohen P et al. (1995) Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg–Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients. Arthritis Rheum 38:1638–1645

    CAS  PubMed  Google Scholar 

  22. Guillevin L, Fain O, Lhote F et al. (1992) Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome. A prospective, randomized trial in 78 patients. Arthritis Rheum 35:208–215

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to D. H. Deeren.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Deeren, D.H., De Backer, A.I., Malbrain, M.L.N.G. et al. Treatment of hepatitis B virus-related polyarteritis nodosa: two case reports and a review of the literature. Clin Rheumatol 23, 172–176 (2004). https://doi.org/10.1007/s10067-003-0857-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-003-0857-4

Keywords

Navigation